-
公开(公告)号:US20120238569A1
公开(公告)日:2012-09-20
申请号:US13399106
申请日:2012-02-17
IPC分类号: A61K31/5377 , C07D417/12 , C07D417/14 , C07D409/12 , C07D409/14 , A61P11/06 , A61K31/427 , A61K31/381 , A61K31/416 , A61K31/506 , A61K31/497 , A61P11/00 , C07D277/56 , A61K31/426
CPC分类号: C07D277/20 , C07D333/04 , C07D409/12 , C07D409/14 , C07D417/12 , C07D417/14
摘要: Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of inflammatory diseases and disorders such as, for example, asthma and COPD.
摘要翻译: 本文提供式(I)的化合物及其药学上可接受的盐,其中取代基如说明书中公开的那些。 这些化合物和含有它们的药物组合物可用于治疗炎性疾病和病症,例如哮喘和COPD。
-
公开(公告)号:US20120270875A1
公开(公告)日:2012-10-25
申请号:US13399117
申请日:2012-02-17
申请人: Paul Gillespie , Christophe Michoud , Kenneth Carey Rupert , Kshitij Chhabilbhai Thakkar , Lin Yi
发明人: Paul Gillespie , Christophe Michoud , Kenneth Carey Rupert , Kshitij Chhabilbhai Thakkar , Lin Yi
IPC分类号: A61K31/5377 , A61K31/506 , C07D413/14 , C07D409/14 , C07D239/42 , C07D409/12 , C07D401/12 , C07D417/14 , A61P11/06 , A61P11/00 , A61K31/505 , A61K31/497 , C07D403/12
CPC分类号: C07D239/42 , C07D401/12 , C07D403/12 , C07D409/12 , C07D409/14 , C07D417/12 , C07D417/14
摘要: Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of inflammatory diseases and disorders such as, for example, asthma and COPD.
摘要翻译: 本文提供式(I)的化合物及其药学上可接受的盐,其中取代基如说明书中公开的那些。 这些化合物和含有它们的药物组合物可用于治疗炎性疾病和病症,例如哮喘和COPD。
-
公开(公告)号:US08404859B2
公开(公告)日:2013-03-26
申请号:US13399106
申请日:2012-02-17
IPC分类号: A61K31/426 , A61K31/381 , C07D417/12 , C07D277/46 , C07D333/38
CPC分类号: C07D277/20 , C07D333/04 , C07D409/12 , C07D409/14 , C07D417/12 , C07D417/14
摘要: Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of inflammatory diseases and disorders such as, for example, asthma and COPD.
摘要翻译: 本文提供式(I)的化合物及其药学上可接受的盐,其中取代基如说明书中公开的那些。 这些化合物和含有它们的药物组合物可用于治疗炎性疾病和病症,例如哮喘和COPD。
-
-